Todd L. Cecil, Ph.D., serves as Acting Director of the Office of Science and the Deputy Director of Regulatory Management in the Office of Science at FDA’s Center for Tobacco Products (CTP). As the Acting Director of the Office of Science since July 2022, Dr. Cecil is responsible for identifying, developing, and enhancing the science related to tobacco products, their use, and the resulting morbidity and mortality so that regulatory decisions will have the greatest impact on improving public health. As Deputy Director of Regulatory Management since summer of 2020, he is responsible for accessing existing scientific evidence and supporting new research to inform regulatory actions intended to protect the public health.

Dr. Cecil joined CTP in 2015 and has served as a chemistry reviewer, Team Lead, Branch Chief and Associate Director of the Division of Product Science. He has also served in the Technical Project Lead role for SE, EX, and PMTA programs. 

Prior to joining FDA, he spent over 23 years at the United States Pharmacopeia (USP), where he served as the Vice-president of Compendial Science. He also served as the USP member of the International Council on Harmonization (ICH) and as the representative of the Pharmacopeial Discussion Group (PDG).  Both organizations focused on developing globally harmonized standards for the pharmaceutical industry and regulatory partners.

Dr. Cecil holds a B.S. in Chemistry from the University of Iowa and Ph.D. in Analytical Chemistry from Virginia Commonwealth University.

Additional Resources

• Sign Up for Email Updates from CTP